65 related articles for article (PubMed ID: 27487797)
1. Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants.
Okubo T; Atsukawa M; Tsubota A; Shimada N; Abe H; Yoshizawa K; Arai T; Nakagawa A; Itokawa N; Kondo C; Aizawa Y; Iwakiri K
Hepatol Res; 2017 Jun; 47(7):641-649. PubMed ID: 27487797
[TBL] [Abstract][Full Text] [Related]
2. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
Peiffer KH; Sommer L; Susser S; Vermehren J; Herrmann E; Döring M; Dietz J; Perner D; Berkowski C; Zeuzem S; Sarrazin C
Hepatology; 2016 Jan; 63(1):63-73. PubMed ID: 26406534
[TBL] [Abstract][Full Text] [Related]
3. "Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline.
Uchida Y; Kouyama JI; Naiki K; Sugawara K; Inao M; Imai Y; Nakayama N; Mochida S
Hepatol Res; 2017 Dec; 47(13):1397-1407. PubMed ID: 28239934
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of semiquantitative PCR-Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b.
Honda K; Seike M; Oribe J; Endo M; Arakawa M; Tokoro M; Iwao M; Mori T; Nishimura J; Takahashi Y; Omori K; Yamashita T; Muro T; Murakami K
Hepatol Res; 2018 Mar; 48(4):255-263. PubMed ID: 29080280
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.
Iio E; Shimada N; Takaguchi K; Senoh T; Eguchi Y; Atsukawa M; Tsubota A; Abe H; Kato K; Kusakabe A; Miyaki T; Matsuura K; Matsunami K; Shinkai N; Fujiwara K; Nojiri S; Tanaka Y
Hepatol Res; 2017 Nov; 47(12):1308-1316. PubMed ID: 28332272
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy.
Itakura J; Kurosaki M; Takada H; Nakakuki N; Matsuda S; Gondou K; Asano Y; Hattori N; Itakura Y; Tamaki N; Yasui Y; Suzuki S; Hosokawa T; Tsuchiya K; Nakanishi H; Takahashi Y; Maekawa S; Enomoto N; Izumi N
Hepatol Res; 2015 Oct; 45(10):E115-21. PubMed ID: 25564756
[TBL] [Abstract][Full Text] [Related]
7. Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism.
Uchida Y; Kouyama JI; Naiki K; Sugawara K; Inao M; Imai Y; Nakayama N; Mochida S
Hepatol Res; 2016 Nov; 46(12):1234-1246. PubMed ID: 26878268
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection.
Ito J; Suda G; Yamamoto Y; Nagasaka A; Furuya K; Kumagai K; Kikuchi H; Miyagishima T; Kobayashi T; Kimura M; Yamasaki K; Umemura M; Izumi T; Tsunematsu S; Sato F; Tsukuda Y; Terashita K; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N;
Hepatol Res; 2016 Dec; 46(13):1294-1303. PubMed ID: 26896756
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
Osawa M; Uchida T; Imamura M; Teraoka Y; Fujino H; Nakahara T; Ono A; Murakami E; Kawaoka T; Miki D; Tsuge M; Hiramatsu A; Abe-Chayama H; Hayes CN; Makokha GN; Aikata H; Ishida Y; Tateno C; Miyayama Y; Hijikata M; Chayama K
J Gen Virol; 2019 Jul; 100(7):1123-1131. PubMed ID: 31199224
[TBL] [Abstract][Full Text] [Related]
10. The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus.
Jones BR; Howe AYM; Harrigan PR; Joy JB
Virus Evol; 2018 Jan; 4(1):vex041. PubMed ID: 29362671
[TBL] [Abstract][Full Text] [Related]
11. Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencing.
Takeda H; Ueda Y; Inuzuka T; Yamashita Y; Osaki Y; Nasu A; Umeda M; Takemura R; Seno H; Sekine A; Marusawa H
Sci Rep; 2017 Mar; 7():45605. PubMed ID: 28361915
[TBL] [Abstract][Full Text] [Related]
12. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients.
Farnik H; Bojunga J; Berger A; Allwinn R; Waidmann O; Kronenberger B; Keppler OT; Zeuzem S; Sarrazin C; Lange CM
Hepatology; 2013 Oct; 58(4):1270-6. PubMed ID: 23703797
[TBL] [Abstract][Full Text] [Related]
13. Effects of resistance-associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.
Suda G; Kimura M; Shigesawa T; Suzuki K; Nakamura A; Ohara M; Kawagishi N; Nakai M; Sho T; Maehara O; Shimazaki T; Morikawa K; Natsuizaka M; Ogawa K; Sakamoto N
Hepatol Res; 2019 Nov; 49(11):1275-1285. PubMed ID: 31261439
[TBL] [Abstract][Full Text] [Related]
14. Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.
Akuta N; Sezaki H; Suzuki F; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
J Med Virol; 2017 Feb; 89(2):284-290. PubMed ID: 27357737
[TBL] [Abstract][Full Text] [Related]
15. Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus.
Wang Y; Rao HY; Xie XW; Wei L
Chin Med J (Engl); 2015 Oct; 128(19):2625-31. PubMed ID: 26415801
[TBL] [Abstract][Full Text] [Related]
16. The practical management of chronic hepatitis C infection in Japan - dual therapy of daclatasvir + asunaprevir.
Expert Rev Gastroenterol Hepatol; ; . PubMed ID: 27936974
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
